Quest Diagnostics Reports Second Quarter 2020 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/24/2026
- Wall Street closes lower to end rocky week
- Meta's capital-raising plans expose a major weakness in the AI boom
- Oil prices jump $3 on Houthi attacks, oil spill, highest settlement since April
- BofA flags further downside risk for stocks, yields and dollar
- SpaceX cell-site ambitions lift tower stocks and weigh on carriers
Quest Diagnostics (DGX) PT Raised to $148 at BofA Securities
July 24, 2020 8:16 AM EDTBofA Securities analyst Derik de Bruin raised the price target on Quest Diagnostics (NYSE: DGX) to $148.00 (from $142.00) while maintaining a Buy rating.
... MoreQuest Diagnostics (DGX) Tops Q2 EPS by 2c; Reiterates FY Outlook
July 23, 2020 6:46 AM EDTQuest Diagnostics (NYSE: DGX) reported Q2 EPS of $1.42, $0.02 better than the analyst estimate of $1.40. Revenue for the quarter came in at $1.83 billion versus the consensus estimate of $1.83 billion.
"In one of the most challenging periods in our history, Quest Diagnostics stepped up and... More



